Use of Standardized Algorithm for the Management of Epidural Analgesia for Labor and Delivery

Sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04814199
Collaborator
(none)
50
1
5.8
8.5

Study Details

Study Description

Brief Summary

Programmed Intermittent Epidural Bolus (PIEB) has become a standard technique for labour analgesia in many departments of anesthesia. Advantages to the former standard of care, continued epidural infusion (CEI), include reduced analgesic consumption , better maternal satisfaction and less occurrence of motor block . At Mount Sinai Hospital, the introduction of a bundle of changes in the management of labor analgesia including the use of PIEB, has resulted in an improvement of the quality of labor analgesia. This bundle of changes included labor catheter placement more often at L2/L3 interspace, more frequent use of fentanyl in the epidural loading dose, the implementation of a PIEB regimen and an increase in hourly baseline offer of local anesthetic.

A recent before-and-after study conducted by the investigators, comparing the current practice with the previous practice, which was based on CEI, identified that the incidence of women experiencing pain >3 (scale 0-10) (40% vs 30%) and the number of nurse-administered top-ups (24% vs 3%) were significantly reduced. However, despite that significant improvement, some 30% of women undergoing epidural analgesia still experience pain NRS >3 (NRS scale 0-10) during either first or second stage of labor.

Although the health care team attempts to manage epidurals as standardized as possible, there is some variation in practice resulting from the many stakeholders involved in the labor analgesia management, including anesthesiologists, obstetricians, nurses and patients. The investigators hypothesized that our most recent results may be explained by the lack of standardization of the management of epidural analgesia and that a standardized epidural catheter placement and a management algorithm may improve the efficacy of our epidural analgesia regimen.

The aim of this pilot study is to test the feasibility and efficacy of the use of a standardized algorithm for the management of labor epidural analgesia based on a PIEB regimen.

Condition or Disease Intervention/Treatment Phase
  • Other: Algorithm

Study Design

Study Type:
Observational
Actual Enrollment :
50 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Use of Standardized Algorithm for the Management of Epidural Analgesia for Labor and Delivery: An Observational Cohort Study
Actual Study Start Date :
May 4, 2021
Actual Primary Completion Date :
Oct 28, 2021
Actual Study Completion Date :
Oct 29, 2021

Arms and Interventions

Arm Intervention/Treatment
Patients using epidural management algorithm

Patients will be educated and given an algorithm to follow while in labour and after having an epidural catheter placed.

Other: Algorithm
Patients will have a printed algorithm to follow while they are in labour with an epidural for pain management.
Other Names:
  • Epidural algorithm
  • Outcome Measures

    Primary Outcome Measures

    1. Pain score, questionnaire [24 hours]

      Pain score using verbal numerical rating scale (VNRS) (0-10, where 0=no pain and 10=worst pain ever). This will be assessed hourly following epidural placement, as per institutional guidelines, until the patient delivers. The primary outcome of the study will be the presence of pain (NRS ≥ 3) at any time during the first and second stage of labor, after the establishment of an effective loading dose (pain NRS ≤ 1/10).

    Secondary Outcome Measures

    1. Upper sensory block level [24 hours]

      The upper sensory block level to ice is defined as the dermatome at which there is an altered cold perception without complete sensitivity loss. This will be assessed hourly following epidural placement, as per institutional guidelines, until the patient delivers.

    2. Motor block score using Bromage score [24 hours]

      Motor block will be assessed with the Bromage score: 0 = able to raise the extended leg; 1 = unable to raise the extended leg but able to flex knees; 2 = unable to flex knees, but able to flex ankle; 3 = unable to flex ankle. This will be assessed hourly following epidural placement, as per institutional guidelines, until the patient delivers.

    3. Blood pressure [24 hours]

      Blood pressure measured hourly following epidural placement, as per institutional guidelines, until the patient delivers.

    4. Heart rate [24 hours]

      Heart rate measured hourly following epidural placement, as per institutional guidelines, until the patient delivers.

    5. Number of patient controlled epidural analgesia button presses [24 hours]

      Need for supplementary analgesia: the number of patient controlled epidural analgesia button presses will be recorded.

    6. Number of top ups administered by nurses or physicians [24 hours]

      Need for supplementary analgesia: the number of top ups administered by nurses or physicians will be recorded.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 55 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • request for epidural analgesia during labor

    • ASA Physical Status II and III

    Exclusion Criteria:
    • patients requiring change in anesthetic management due to comorbidities or complications before initiation of epidural analgesia maintenance will be excluded.

    • refusal to give written informed consent

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Mount Sinai Hospital Toronto Ontario Canada M5G1X5

    Sponsors and Collaborators

    • Samuel Lunenfeld Research Institute, Mount Sinai Hospital

    Investigators

    • Principal Investigator: Jose Carvalho, MD, MOUNT SINAI HOSPITAL

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Samuel Lunenfeld Research Institute, Mount Sinai Hospital
    ClinicalTrials.gov Identifier:
    NCT04814199
    Other Study ID Numbers:
    • 21-02
    First Posted:
    Mar 24, 2021
    Last Update Posted:
    Jan 31, 2022
    Last Verified:
    May 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Samuel Lunenfeld Research Institute, Mount Sinai Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 31, 2022